AYOXXA Trademark Information

AyoxxA Biosystems GmbH

Pharmaceutical preparations for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; veterinary pharmaceutical preparations for treatment of gastro-intes...

Perfect for these industries

This is a brand page for the AYOXXA trademark by AyoxxA Biosystems GmbH  in , , .

Write a review about a product or service associated with this AYOXXA trademark. Or, contact the owner AyoxxA Biosystems GmbH of the AYOXXA trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the AYOXXA trademark.

On Friday, October 6, 2017, a U.S. federal trademark registration was filed for AYOXXA. The USPTO has given the AYOXXA trademark serial number of 79224525. The current federal status of this trademark filing is REGISTERED. The correspondent listed for AYOXXA is Joyce von Natzmer of Agris & von Natzmer LLP, 43 West 43rd Street, Suite 104, New York NY 10036 . The AYOXXA trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for AYOXXA is Pharmaceutical preparations for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; veterinary pharmaceutical preparations for treatment of gastro-intestinal diseases, treatment of inflammatory diseases, treatment of ophthalmic diseases, and treatment of mucosa irritations; diagnostic agents for medical purposes; diagnostic agents for veterinary purposes; chemical and biochemical preparations for medical purposes, namely, for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; chemical and biochemical reagents for medical purposes; chemical and biochemical preparations for veterinary purposes, namely, for treatment of gastro-intestinal diseases, treatment of inflammatory diseases, treatment of ophthalmic diseases, and treatment of mucosa irritations; chemical and biochemical reagents for veterinary purposes; chemical and biochemical preparations for pharmaceutical purposes, namely, for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; chemical and biochemical reagents for medical or veterinary pharmaceutical purposes; biological agents for laboratory analyses for medical purposes, namely, peptides, proteins and nucleic acids used as diagnostic agents for medical purposes; biological agents for laboratory analyses for veterinary purposes, namely, peptides, proteins and nucleic acids used as diagnostic agents for veterinary purposes; chemical and biochemical preparations and reagents for medical purposes, namely, for use in DNA analyses; chemical and biochemical preparations for blood tests for medical purposes; chemical and biochemical reagents for blood tests for medical purposes; chemical and biochemical preparations for blood tests for veterinary purposes; chemical and biochemical reagents for blood tests for veterinary purposes; peptides, proteins, nucleic acids and other biomolecules, or complexes of these molecules, for medical purposes, namely, synthetic or natural peptides, proteins, allergens, metabolites or nucleic acids for the treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases, protein arrays for medical diagnosis purposes, nucleic acid sequences for medical diagnosis purposes; proteins, nucleic acids and other biomolecules, or complexes of these molecules, for veterinary purposes, namely, synthetic or natural peptides, proteins, allergens, metabolites or nucleic acids for treatment of gastro-intestinal diseases, treatment of inflammatory diseases, treatment of ophthalmic diseases, and treatment of mucosa irritations in animals, protein arrays for veterinary diagnosis purposes, nucleic acid sequences for veterinary diagnosis purposes; chemical and biochemical preparations and reagents for labelling of molecules for medical detection and monitoring purposes; chemical and biochemical preparations and reagents for labelling of molecules for veterinary detection and monitoring purposes.

Word mark: AYOXXA
Status/Status Date:
REGISTERED
3/26/2019
Serial Number: 79224525
Filing Date: 10/6/2017
Registration Number: 5705785
Registration Date: 3/26/2019
Goods and Services: Pharmaceutical preparations for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; veterinary pharmaceutical preparations for treatment of gastro-intestinal diseases, treatment of inflammatory diseases, treatment of ophthalmic diseases, and treatment of mucosa irritations; diagnostic agents for medical purposes; diagnostic agents for veterinary purposes; chemical and biochemical preparations for medical purposes, namely, for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; chemical and biochemical reagents for medical purposes; chemical and biochemical preparations for veterinary purposes, namely, for treatment of gastro-intestinal diseases, treatment of inflammatory diseases, treatment of ophthalmic diseases, and treatment of mucosa irritations; chemical and biochemical reagents for veterinary purposes; chemical and biochemical preparations for pharmaceutical purposes, namely, for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; chemical and biochemical reagents for medical or veterinary pharmaceutical purposes; biological agents for laboratory analyses for medical purposes, namely, peptides, proteins and nucleic acids used as diagnostic agents for medical purposes; biological agents for laboratory analyses for veterinary purposes, namely, peptides, proteins and nucleic acids used as diagnostic agents for veterinary purposes; chemical and biochemical preparations and reagents for medical purposes, namely, for use in DNA analyses; chemical and biochemical preparations for blood tests for medical purposes; chemical and biochemical reagents for blood tests for medical purposes; chemical and biochemical preparations for blood tests for veterinary purposes; chemical and biochemical reagents for blood tests for veterinary purposes; peptides, proteins, nucleic acids and other biomolecules, or complexes of these molecules, for medical purposes, namely, synthetic or natural peptides, proteins, allergens, metabolites or nucleic acids for the treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases, protein arrays for medical diagnosis purposes, nucleic acid sequences for medical diagnosis purposes; proteins, nucleic acids and other biomolecules, or complexes of these molecules, for veterinary purposes, namely, synthetic or natural peptides, proteins, allergens, metabolites or nucleic acids for treatment of gastro-intestinal diseases, treatment of inflammatory diseases, treatment of ophthalmic diseases, and treatment of mucosa irritations in animals, protein arrays for veterinary diagnosis purposes, nucleic acid sequences for veterinary diagnosis purposes; chemical and biochemical preparations and reagents for labelling of molecules for medical detection and monitoring purposes; chemical and biochemical preparations and reagents for labelling of molecules for veterinary detection and monitoring purposes
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 1/8/2019
Last Applicant/Owner: AyoxxA Biosystems GmbH
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
Agris & von Natzmer LLP
43 West 43rd Street, Suite 104
New York NY 10036

Trademark Events

Event Date: Event Description
2019-08-16 FINAL DECISION TRANSACTION PROCESSED BY IB
2019-07-25 FINAL DISPOSITION NOTICE SENT TO IB
2019-07-25 FINAL DISPOSITION PROCESSED
2019-06-26 FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2019-03-26 REGISTERED-PRINCIPAL REGISTER
2019-01-08 OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-01-08 PUBLISHED FOR OPPOSITION
2018-12-19 NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-11-14 APPROVED FOR PUB - PRINCIPAL REGISTER
2018-10-22 ASSIGNED TO EXAMINER
2018-09-21 TEAS/EMAIL CORRESPONDENCE ENTERED
2018-09-21 CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-09-21 TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-04-06 REFUSAL PROCESSED BY IB
2018-03-22 NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2018-03-22 REFUSAL PROCESSED BY MPU
2018-03-22 NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2018-03-21 NON-FINAL ACTION WRITTEN
2018-02-16 NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
2018-02-07 NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2018-02-06 NON-FINAL ACTION WRITTEN
2018-01-16 ASSIGNED TO EXAMINER
2018-01-16 APPLICATION FILING RECEIPT MAILED
2018-01-10 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-01-04 SN ASSIGNED FOR SECT 66A APPL FROM IB

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your AYOXXA trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Just $199 + govt fees! Start here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.
Current Trademark Status:
3/26/2019
REGISTERED
Correspondent Search:

Joyce von Natzmer is a correspondent of AYOXXA trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!